Organisation paid for research Program year 2021 Source: CMS Open Payments

Via Christi Research

Neither a doctor nor a teaching hospital

Research payments

$8,386

7 payments

Through program year 2021, Via Christi Research is reported as receiving $8,386 in research payments, across 7 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2021	Research	$2,829	1
2020	Research	$2,795	4
2019	Research	$2,761	2

Breakdown

Who paid Research payments · program years 2019–2021

Merck Sharp & Dohme Corporation $8,386 7 payments

Studies the money was for Research payments · program years 2019–2021

A Phase III Multicenter, Open-Label, Randomized, Study to Evaluate a Switch to MK-1439A in HIV-1-Infected Subjects Virologically Suppressed on a Regimen of a Ritonavir-boosted Protease Inhibitor and Two Nucleoside Reverse Transcriptase Inhibitors NRTIs $5,487 2 payments
A Phase III Multicenter, Open-Label, Randomized, Study to Evaluate a Switch to MK-1439A in HIV-1-Infected Subjects Virologically Suppressed on a Regimen of a Ritonavir-boosted Protease Inhibitor and Two Nucleoside Reverse Transcriptase Inhibitors NRTIs $2,829 1 payment
A Phase III Multicenter, Open-Label, Randomized, Study to Evaluate a Switch to MK-1439A in HIV-1-Infected Subjects Virologically Suppressed on a Regimen of a Ritonavir-boosted Protease Inhibitor and Two Nucleoside Reverse Transcriptase Inhibitors NRTIs $52 3 payments
A Phase III Multicenter, Double-Blind, Randomized, Active Comparator-Controlled Clinical Trial to Evaluate the Safety and Efficacy of MK-1439A Once-Daily Versus ATRIPLA Once-Daily in Treatment-Na ve HIV-1 Infected Subjects $18 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.